The integration profile of EIAV-based vectors

被引:38
|
作者
Hacker, Caroline V.
Vink, Conrad A.
Wardell, Theresa W.
Lee, Sheena
Treasure, Peter
Kingsman, Susan M.
Mitrophanous, Kyriacos A.
Miskin, James E.
机构
[1] Oxford BioMedica UK Ltd, Medawar Ctr, Oxford OX4 4GA, England
[2] Peter Treasure Stat Serv Ltd, Kings Lynn PE34 3NR, England
关键词
lentiviral vectors; EIAV; gene therapy; integration; safety;
D O I
10.1016/j.ymthe.2006.06.006
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Lentiviral vectors based on equine infectious anemia virus (EIAV) stably integrate into dividing and nondividing cells such as neurons, conferring long-term expression of their transgene. The integration profile of an EIAV vector was analyzed in dividing HEK293T cells, alongside an HIV-1 vector as a control, and compared to a random dataset generated in silico. A multivariate regression model was generated and the influence of the following parameters on integration site selection determined: (a) within/not within a gene, (b) GC content within 20 kb, (c) within 10 kb of a CpG island, (d) gene density within a 2-Mb window, and (e) chromosome number. The majority of the EIAV integration sites (68%; n = 458) and HIV-1 integration sites (72%; n = 162) were within a gene, and both vectors favored AT-rich regions. Sites within genes were examined using a second model to determine the influence of the gene-specific parameters, gene region, and transcriptional activity. Both EIAV and HIV-1 vectors preferentially integrated within active genes. Unlike the gammaretrovirus MLV, EIAV and HIV-1 vectors do not integrate preferentially into the promoter region or the 5' end of the transcription unit.
引用
收藏
页码:536 / 545
页数:10
相关论文
共 50 条
  • [1] EIAV-based vectors for the treatment of haemophilia A
    Radcliffe, PA
    Wilkes, FJ
    Beard, GL
    Kingsman, SM
    Mitrophanous, KA
    MOLECULAR THERAPY, 2004, 9 : S64 - S64
  • [2] New methods to titrate EIAV-based lentiviral vectors
    Martin-Rendon, E
    White, LJ
    Olsen, A
    Mitrophanous, KA
    Mazarakis, ND
    MOLECULAR THERAPY, 2002, 5 (05) : 566 - 570
  • [3] Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction
    Beutelspacher, SC
    Ardjomand, N
    Tan, PH
    Patton, GS
    Larkin, DFP
    George, AJT
    McClure, MO
    EXPERIMENTAL EYE RESEARCH, 2005, 80 (06) : 787 - 794
  • [4] Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cells
    Siapati, EK
    Bigger, BW
    Miskin, J
    Chipchase, D
    Parsley, KL
    Mitrophanous, K
    Themis, M
    Thrasher, AJ
    Bonnet, D
    MOLECULAR THERAPY, 2005, 12 (03) : 537 - 546
  • [5] Non-primate EIAV-based lentiviral vectors as gene delivery system for motor neuron diseases
    Azzouz, M
    Mazarakis, N
    CURRENT GENE THERAPY, 2004, 4 (03) : 277 - 286
  • [6] Reversal of hypothalamic diabetes insipidus using EIAV-based regulatable lentiviral vectors expressing arginine vasopressin
    Radcliffe, BP
    Cosgrave, S
    Mitrophanous, K
    Mazarakis, N
    Uney, JB
    JOURNAL OF GENE MEDICINE, 2004, 6 (09): : S35 - S36
  • [7] Reversal of hypothalamic diabetes insipidus using EIAV-based regulatable lentiviral vectors expressing arginine vasopressin
    Bienemann, A
    Radcliffe, P
    Mitrophanous, K
    Glover, C
    Mazarakis, N
    Uney, J
    MOLECULAR THERAPY, 2004, 9 : S241 - S241
  • [8] High Efficiency Gene Transfer to Airways of Mice Using Influenza Hemagglutinin Pseudotyped EIAV-Based Lentivirus Vectors
    Patel, Manij
    Giddings, Angela M.
    Olsen, John C.
    MOLECULAR THERAPY, 2009, 17 : S30 - S30
  • [9] Evaluation of EIAV-based lentiviral vectors following ocular delivery in the non-human primate model:: Development of RetinoStat®
    Binley, Katie
    Iqball, Sharifah
    Nork, T. Michael
    Miller, Paul
    Christian, Brian
    Kan, On
    Naylor, Stuart
    HUMAN GENE THERAPY, 2007, 18 (10) : 1027 - 1028
  • [10] Development of inducible EIAV-based lentiviral vector packaging and producer cell lines
    Stewart, H. J.
    Leroux-Carlucci, M. A.
    Sion, C. J. M.
    Mitrophanous, K. A.
    Radcliffe, P. A.
    GENE THERAPY, 2009, 16 (06) : 805 - 814